These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8593006)

  • 1. Critical influence of timing of administration of granulocyte colony-stimulating factor on antibacterial effect in experimental endocarditis due to Pseudomonas aeruginosa.
    Vignes S; Fantin B; Elbim C; Walker F; Gougerot-Pocidalo MA; Carbon C
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2702-7. PubMed ID: 8593006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
    Neelis KJ; Hartong SC; Egeland T; Thomas GR; Eaton DL; Wagemaker G
    Blood; 1997 Oct; 90(7):2565-73. PubMed ID: 9326222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells.
    Andrews RG; Briddell RA; Knitter GH; Opie T; Bronsden M; Myerson D; Appelbaum FR; McNiece IK
    Blood; 1994 Aug; 84(3):800-10. PubMed ID: 7519077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis.
    Opal SM; Jhung JW; Keith JC; Goldman SJ; Palardy JE; Parejo NA
    Blood; 1999 May; 93(10):3467-72. PubMed ID: 10233899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the prophylactic and therapeutic effect of human granulocyte-colony stimulating factor (G-CSF) on experimental pyelonephritis induced by pseudomonas aeruginosa in neutropenic mice].
    Tanaka N; Kumamoto Y; Hirose T; Yokoo A
    Kansenshogaku Zasshi; 1989 Feb; 63(2):145-55. PubMed ID: 2473150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Staphylococcus aureus catheter-related infection and infective endocarditis with granulocyte colony-stimulating factor in the experimental rabbit model.
    Frank U; Chambers HF
    Antimicrob Agents Chemother; 1996 May; 40(5):1308-10. PubMed ID: 8723492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia.
    Wright DG; Kenney RF; Oette DH; LaRussa VF; Boxer LA; Malech HL
    Blood; 1994 Aug; 84(4):1257-67. PubMed ID: 7519479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
    Cairo MS; Plunkett JM; Schendel P; van de Ven C
    Exp Hematol; 1994 Oct; 22(11):1118-23. PubMed ID: 7523164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.
    Gillan ER; Christensen RD; Suen Y; Ellis R; van de Ven C; Cairo MS
    Blood; 1994 Sep; 84(5):1427-33. PubMed ID: 7520770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of delayed granulocyte colony-stimulating factor after full dose CHOP therapy in non-Hodgkin's lymphoma: a pilot study for a leukocyte count oriented regimen.
    Sawada KI; Sato N; Kohno M; Hannda H; Yasukouchi T; Tanngo M; Hirayama A; Koike T
    Leuk Lymphoma; 1995 Dec; 20(1-2):103-9. PubMed ID: 8750630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis.
    Cairo MS; Plunkett JM; Mauss D; Van de ven C
    Blood; 1990 Nov; 76(9):1788-94. PubMed ID: 1699622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of granulocyte colony-stimulating factor in modifying mortality from Pseudomonas aeruginosa pneumonia after hemorrhage.
    Abraham E; Stevens P
    Crit Care Med; 1992 Aug; 20(8):1127-33. PubMed ID: 1379529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa.
    Bayer AS; Park S; Ramos MC; Nast CC; Eftekhar F; Schiller NL
    Infect Immun; 1992 Oct; 60(10):3979-85. PubMed ID: 1398909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of infective endocarditis with granulocyte colony-stimulating factor.
    Hanazono Y; Miyazono K; Tsuchimochi H; Yamaoki K; Miyagawa K; Hirai H; Yazaki Y; Takaku F
    Jpn J Med; 1991; 30(6):593-6. PubMed ID: 1724676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa.
    Xiong YQ; Potel G; Caillon J; Stephant G; Jehl F; Bugnon D; Le Conte P; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1995 Feb; 39(2):496-9. PubMed ID: 7726520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopoiesis: in vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis.
    Cairo MS; Plunkett JM; Nguyen A; van de Ven C
    Blood; 1992 Jul; 80(1):96-101. PubMed ID: 1377057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of human recombinant granulocyte-colony stimulating factor treatment during in vitro maturation of porcine oocyte on subsequent embryonic development.
    Cai L; Jeon Y; Yoon JD; Hwang SU; Kim E; Park KM; Kim KJ; Jin MH; Lee E; Kim H; Jeung EB; Hyun SH
    Theriogenology; 2015 Oct; 84(7):1075-87. PubMed ID: 26194698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.